Lixte Biotechnology
LIXT
LIXT
9 hedge funds and large institutions have $385K invested in Lixte Biotechnology in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$81.7K | |
| 2 | +$29.7K | |
| 3 | +$7.67K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.47K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$183 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIA
1
FNY Investment Advisers
New York
| $129K |
|
|||
2
HighTower Advisors
Chicago,
Illinois
| $120K |
|
|||
|
EFG
3
Ethos Financial Group
King Of Prussia,
Pennsylvania
| $50.4K |
|
|||
4
Citadel Advisors
Miami,
Florida
| $29.7K |
|
|||
|
5
Geode Capital Management
Boston,
Massachusetts
| $27.9K |
|
|||
|
ALA
6
Atlas Legacy Advisors
Los Angeles,
California
| $17.2K |
|
|||
7
UBS Group
Zurich,
Switzerland
| $10K |
|
|||
|
SS
8
SBI Securities
Tokyo,
Japan
| $229 |
|
|||
9
Bank of America
Charlotte,
North Carolina
| $25 |
|
|||
10
TIAA Trust, National Association
Charlotte,
North Carolina
| – |
|
|||
|
TRCT
11
Tower Research Capital (TRC)
New York
| – |
|